Journal
MOLECULAR MEDICINE REPORTS
Volume 14, Issue 1, Pages 1026-1032Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/mmr.2016.5340
Keywords
rectal cancer; high-mobility group protein 1; cell apoptosis; caspase-3
Categories
Ask authors/readers for more resources
Rectal cancer is a malignant gastrointestinal tumor, which is associated with high morbidity and mortality. High-mobility group protein 1 (HMGB1) is widely present in the nucleus of eukaryotic cells, and is highly conserved between humans and rodents. Recently, HMGB1 has been reported to be involved in the progression and metastasis of human cancer; however, its role in the development and metastasis of human rectal cancer remains unclear. The present study detected the expression levels of HMGB1 in pathological specimens from patients with clinically identified rectal cancer using immunohistochemistry and western blotting. The results demonstrated that HMGB1 was highly expressed in samples from patients with rectal cancer. The positive rate of HMGB1 in rectal cancer tissues was 96.08% (49/51), which was significantly higher compared with 3.92% (2/51) in normal tissues. In addition, western blotting indicated that HMGB1 was distributed and located not only in the nucleus, but also in the cytoplasm of colorectal cancer cells. HMGB1-specific short hairpin (sh)RNA was used to silence the endogenous expression of HMGB1 in colorectal cancer cells. A functional assay demonstrated that knockdown of endogenous HMGB1 expression significantly inhibited the proliferation of SW620 and Colo320 cells. Furthermore, western blotting revealed that knockdown of endogenous HMGB1 expression contributed to activation of caspase-3 and the substrate poly (ADP-ribose) polymerase. The expression levels of B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X protein (Bax) were also detected by western blotting. As expected, decreased levels of Bcl-2 and increased levels of Bax were detected in the HMGB1 shRNA-transfected colorectal cancer cells, and the Bax/Bcl-2 ratio was increased in HMGB1 shRNA-transfected cells. These data indicated that HMGB1 may act as an oncogene in rectal cancer, and knockdown of endogenous HMGB1 expression may significantly inhibit the proliferation of colorectal cancer cells and promote apoptosis of tumor cells. Further research regarding the mechanisms underlying the effects of HMGB1 on the progression of rectal cancer may provide novel targets for the treatment of rectal cancer, and provide a theoretical reference for clinical treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available